Fulgent Genetics, Inc. (FLGT)
24.70
-0.15
(-0.60%)
USD |
NASDAQ |
Nov 13, 16:00
24.70
0.00 (0.00%)
After-Hours: 19:59
Fulgent Genetics Shareholders Equity (Quarterly) : 990.49M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 990.49M |
| June 30, 2026 | 1.002B |
| March 31, 2026 | 1.050B |
| December 31, 2025 | 1.112B |
| September 30, 2025 | 1.126B |
| June 30, 2025 | 1.117B |
| March 31, 2025 | 1.127B |
| December 31, 2024 | 1.133B |
| September 30, 2024 | 1.138B |
| June 30, 2024 | 1.133B |
| March 31, 2024 | 1.130B |
| December 31, 2023 | 1.136B |
| September 30, 2023 | 1.259B |
| June 30, 2023 | 1.260B |
| March 31, 2023 | 1.264B |
| December 31, 2022 | 1.267B |
| September 30, 2022 | 1.277B |
| June 30, 2022 | 1.305B |
| March 31, 2022 | 1.306B |
| December 31, 2021 | 1.159B |
| September 30, 2021 | 1.037B |
| June 30, 2021 | 912.73M |
| Date | Value |
|---|---|
| March 31, 2021 | 801.57M |
| December 31, 2020 | 569.39M |
| September 30, 2020 | 186.96M |
| June 30, 2020 | 87.04M |
| March 31, 2020 | 81.37M |
| December 31, 2019 | 82.78M |
| September 30, 2019 | 54.53M |
| June 30, 2019 | 51.14M |
| March 31, 2019 | 49.96M |
| December 31, 2018 | 51.15M |
| September 30, 2018 | 52.58M |
| June 30, 2018 | 52.56M |
| March 31, 2018 | 53.02M |
| December 31, 2017 | 54.18M |
| September 30, 2017 | 55.27M |
| June 30, 2017 | 55.73M |
| March 31, 2017 | 55.30M |
| December 31, 2016 | 54.48M |
| September 30, 2016 | 17.24M |
| June 30, 2016 | 21.70M |
| March 31, 2016 | |
| December 31, 2015 | 5.146M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 7.632B |
| Labcorp Holdings, Inc. | 8.848B |
| OPKO Health, Inc. | 1.116B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 800.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.079B |
| Total Liabilities (Quarterly) | 94.22M |
| Debt to Equity Ratio | 0.0105 |
| Current Ratio | 5.339 |
| Net Debt Paydown Yield | -0.08% |